Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China.
Qiaoyu ZhangBinhua DongLihua ChenTingting LinYao TongWenyu LinHaifeng LinYuqin GaoFen LinPeng-Ming SunPublished in: Cancer management and research (2020)
TP HR-HPV follow-up can provide a reliable and sensitive clinical reference for CIN 2+ postoperative patients.